Inve India ▾

Rossari Biotech share price & results

Rossari Biotech Limited· Chemicals· Commodities

Results to
Sept 2026
Latest analysed call
Q2 FY27
Ownership as of
Sept 2026

Specialty chemicals maker for home & personal care, textiles and animal health, built via Unitop and Tristar acquisitions.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue495 ₹ crore+17.9% YoYQuarterly, as filedQuarter to Sept 2026Revenue from operations as filed.
Operating margin12.0 %0.0 pts YoYOperating profit / revenueQuarter to Sept 2026For the quarter; a change is in percentage points.
Net profit34.0 ₹ crore+9.7% YoYQuarterly, as filedQuarter to Sept 2026Profit after tax as filed.
Return on equity10.87 %−1.5 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-7.35 %−6.3 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)19.75 %+1.6 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Guidance

What management said, and what became of it

2 of 4 judged targets kept · 21 open · verdicts reflect calls analysed to Q2 FY27.

Rossari Biotech Limited management guidance track record on Inve: 25 targets tracked across analysed earnings calls (2 achieved, 2 missed, 21 open).

TargetOriginal wordingSaidLatest callVerdict
Core B2B EBITDA Margin14% - 16%
Call transcript, Q2 FY26 · 17 Oct 2025		Q2 FY26Q2 FY27:Core B2B EBITDA margin came in at 14.1% in Q2 FY27 (down from 14.8% in Q2 FY26 due to doubled/tripled export freight costs), remaining at the bottom edge of the 14%-16% guided range.
Call transcript, Q2 FY27 · 19 Oct 2026		Achieved*
Institutional Cleaning Sales (FY25)₹250 crores
Call transcript, Q2 FY25 · 21 Oct 2024		Q2 FY25Q2 FY27:This promise pertains to a prior fiscal year and is considered closed.
Call transcript, Q2 FY27 · 19 Oct 2026		Achieved
Institutional Cleaning Sales (2-Year Target)Rs. 450 – Rs. 500 crore in 2 years
Call transcript, Q3 FY25 · 23 Jan 2025		Q3 FY25Q2 FY27:Institutional and B2C revenue grew just 3% YoY to ₹77.7 crore (~₹311 crore annualized run rate) as management continues portfolio rationalization and plans to eventually exit non-core B2C operations.
Call transcript, Q2 FY27 · 19 Oct 2026		Revised Down

Source: Inve Guidance Tracker for Rossari Biotech Limited · to Q2 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

2 of Rossari Biotech Limited's 25 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 22 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹408.35 +0.49% · +₹2

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −37.2% 1Y

₹400₹500₹600Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 24 Oct 2025Q3 FY26 — 19 Jan 2026Q4 FY26 — 28 Apr 2026Q1 FY27 — 20 Jul 2026Q2 FY27 — 19 Oct 2026

1Y: ₹650.4 on 24 Oct 2025 → ₹408.35. High ₹653.1 (27 Oct 2025), low ₹378.6 (30 Mar 2026).

Previous close
₹406.35
Market cap
₹2.3k Cr
52-week range
₹378.6 – ₹653.1
One year
−37.48%
Price to earnings (TTM to Sept 2026)
15.01×
Return on equity (TTM to Sept 2026)
10.87%

Overview

Symbol
NSE:ROSSARI
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Rossari Biotech Limited does

Based on the company's own presentations, annual report and earnings calls.

Rossari Biotech manufactures specialty chemical formulations - surfactants, ethoxylates, enzymes, textile auxiliaries and animal-feed additives - sold to industrial and institutional customers in India and abroad. It operates through three reported businesses (HPPC, TSC and AHN) and two acquired manufacturing subsidiaries, Unitop Chemicals (surfactants, ethoxylates, agrochemical and oil & gas chemicals) and Tristar Intermediates (preservatives, aroma chemicals and distillation-based specialty ingredients). Products are manufactured at plants in Dahej and Silvassa (Gujarat/Dadra & Nagar Haveli) and Sarigam, and sold domestically as well as exported, supported by in-house R&D centres that develop new formulations.

Segments

  • HPPC (Home, Personal Care and Performance Chemicals)
  • TSC (Textile Specialty Chemicals)
  • AHN (Animal Health and Nutrition)
Manufacturing facilities
7, across Dahej (Rossari and Unitop plants), Silvassa (Rossari) and Sarigam (Tristar, 3 units)
Total installed manufacturing capacity
382,100 MTPA (including production capacity of subsidiaries Unitop and Tristar)
R&D facilities
4, including a new consolidated R&D facility at Koparkhairane, Navi Mumbai that replaced the earlier IIT Bombay campus lab
Export footprint
Export operations in 80 countries
Product formulations/SKUs
4,300+ formulations across HPPC, TSC and AHN divisions
Customer base
3,010+ total customers (HPPC 1,750+, TSC 1,000+, AHN 125+)
Founded 2003 Company website

How the price took the results

close before → close after

Q2 FY27
−3.8%
19 Oct
Q1 FY27
−2.4%
20 Jul
Q4 FY26
−7.0%
28 Apr
Q3 FY26
−2.5%
19 Jan

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Rossari Biotech Limited

Free account: one company. Everything above stays public.

Write why you follow Rossari Biotech Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Rossari Biotech Limited

Guides on how to read this kind of business and the numbers that matter.